The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson’s disease
Authors
Keywords
Parkinson’s disease, Oxidative stress, Nesfatin-1, GLP-1
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-06
DOI
10.1007/s10072-019-03975-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroprotection of rhGLP-1 in diabetic rats with cerebral ischemia/reperfusion injury via regulation of oxidative stress, EAAT2, and apoptosis
- (2018) Yi Fang et al. DRUG DEVELOPMENT RESEARCH
- Trophic factors for Parkinson's disease: Where are we and where do we go from here?
- (2018) Gesine Paul et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses
- (2018) Sohaila Erfani et al. METABOLIC BRAIN DISEASE
- Immune system responses in Parkinson's disease: Early and dynamic
- (2018) Malú G. Tansey et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction
- (2018) Y. Diz-Chaves et al. Journal of Neuroinflammation
- Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway
- (2017) Arda Tasatargil et al. PEPTIDES
- Influence of Bariatric Surgery on the Expression of Nesfatin-1 in Rats with Type 2 Diabetes Mellitus
- (2015) Zefeng Xia et al. CURRENT PHARMACEUTICAL DESIGN
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells
- (2015) Zhen Tan et al. PEPTIDES
- The protective effect of nesfatin-1 against renal ischemia–reperfusion injury in rats
- (2015) Guanjun Jiang et al. RENAL FAILURE
- Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons
- (2014) Mohammad-Saeid Jami et al. BMC NEUROSCIENCE
- Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson’s disease
- (2013) Aynur Kirbas et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Nesfatin-1 Decreases Excitability of Dopaminergic Neurons in the Substantia Nigra
- (2013) Chen Li et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease
- (2013) Sudhakar Raja Subramaniam et al. PROGRESS IN NEUROBIOLOGY
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
- (2012) Tiziana Alberio et al. IUBMB LIFE
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- (2012) David N. Hauser et al. NEUROBIOLOGY OF DISEASE
- Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease
- (2012) Mustafa Varçin et al. Oxidative Medicine and Cellular Longevity
- Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
- (2011) Vladimer Darsalia et al. CLINICAL SCIENCE
- Minireview: Nesfatin-1—An Emerging New Player in the Brain-Gut, Endocrine, and Metabolic Axis
- (2011) Andreas Stengel et al. ENDOCRINOLOGY
- Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities
- (2011) Enrico Mossello et al. Experimental Diabetes Research
- Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains
- (2011) Rajeswara Babu Mythri et al. NEUROCHEMICAL RESEARCH
- Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease
- (2011) C. Venkateshappa et al. NEUROCHEMICAL RESEARCH
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Oxidative and nitrosative stress in Parkinson's disease
- (2008) Anthony H.K. Tsang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mitochondria in the aetiology and pathogenesis of Parkinson's disease
- (2008) Anthony HV Schapira LANCET NEUROLOGY
- Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population
- (2007) Aabha Sharma et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started